Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VDR | P11473 | 15/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.74 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.74 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | CYP24A1 | Q07973 | 2/20 | 0.71 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.71 |
| ▸ | GC | P02774 | 1/20 | 0.71 |
| ▸ | PGR | P06401 | 1/20 | 0.71 |
| ▸ | RXRA | P19793 | 1/20 | 0.71 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.71 |
| ▸ | CNR1 | P21554 | 1/20 | 0.71 |
| ▸ | HTR2C | P28335 | 1/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.71 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.71 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.71 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.71 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11442771 | 1.00 | VDR (1.00) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL3679281 | 0.91 | VDR (0.83) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL10704733 | 0.90 | VDR (0.82) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL11310229 | 0.90 | VDR (0.82) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL11317480 | 0.88 | VDR (0.78) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL19988221 | 0.88 | VDR (0.78) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL11208271 | 0.88 | VDR (0.78) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL11208266 | 0.88 | VDR (0.78) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL11206665 | 0.88 | VDR (0.78) | VDRADORA3SLC6A2AGTR1MAPT | |
| SCHEMBL11206661 | 0.88 | VDR (0.78) | VDRADORA3SLC6A2AGTR1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025101030-A1 | NANOSTRUCTURE COMPRISING CYCLODEXTRIN-DERIVED POLYMER MATERIAL AND GUEST MATERIAL, AND USE THEREOF | 한국과학기술연구원 | 2025-05-15 | — | — | WO | claimed |
| EP-4065592-B1 | COCRYSTALS OF STEROID AND SECOSTEROID COMPOUNDS AND COMPOSITIONS COMPRISING THEM | CENTER FOR INTELLIGENT RES IN CRYSTAL ENGINEERING S L (ES) | 2024-01-10 | — | — | EP | claimed |
| US-11555007-B2 | Compositions and methods for the treatment of neurological diseases | CELLIX BIO PRIVATE LIMITED (IN) | 2023-01-17 | — | — | US | claimed |
| US-20230001012-A1 | COCRYSTALS OF STEROID AND SECOSTEROID COMPOUNDS AND COMPOSITIONS COMPRISING THEM | CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L. (ES) | 2023-01-05 | — | — | US | claimed |
| CN-115420812-A | Method for detecting calcitronic acid in urine and application thereof | 复旦大学附属华山医院 | 2022-12-02 | — | — | CN | claimed |
| EP-4065592-A1 | COCRYSTALS OF STEROID AND SECOSTEROID COMPOUNDS AND COMPOSITIONS COMPRISING THEM | Center for Intelligent Research in Crystal Engineering, S.L. (ES) | 2022-10-05 | — | — | EP | claimed |
| US-20220105052-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2022-04-07 | — | — | US | claimed |
| US-20220033360-A1 | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES | CELLIX BIO PRIVATE LIMITED (IN) | 2022-02-03 | — | — | US | claimed |
| US-20210244687-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2021-08-12 | — | — | US | claimed |
| EP-3860592-A1 | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES | CELLIX BIO PRIVATE LIMITED (IN) | 2021-08-11 | — | — | EP | claimed |
| US-20190350877-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2019-11-21 | — | — | US | claimed |
| EP-3558279-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2019-10-30 | — | — | EP | claimed |
| WO-2019186357-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DISEASES | CELLIX BIO PRIVATE LIMITED (IN) | 2019-10-03 | — | — | WO | claimed |
| US-20190275010-A1 | COMBINATION THERAPY COMPRISING A THIAZOLE AND A SECOSTEROID TO TREAT SKIN CONDITIONS | AVEXXIN AS (NO) | 2019-09-12 | — | — | US | claimed |
| EP-3534956-A1 | COMBINATION THERAPY COMPRISING A THIAZOLE AND A SECOSTEROID TO TREAT SKIN CONDITIONS | Avexxin AS (NO) | 2019-09-11 | — | — | EP | claimed |
| US-20190209585-A1 | COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A SECOSTEROID | AVEXXIN AS (NO) | 2019-07-11 | — | — | US | claimed |
| EP-3463471-A1 | COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A SECOSTEROID | Avexxin AS (NO) | 2019-04-10 | — | — | EP | claimed |
| WO-2018122626-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2018-07-05 | — | — | WO | claimed |
| WO-2017207818-A1 | COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A SECOSTEROID | AVEXXIN AS (NO) | 2017-12-07 | — | — | WO | claimed |
| US-4585741-A | RADIOIMMUNOASSAY, CALCITROIC ACID AS IMMUNOGEN | CLEVINGER BRIAN L (US) | 1986-04-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210244687-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | F5, OPRK1, F12 | VDR 703/4885ADORA3 1172/4885SLC6A2 719/4885 |
| US-20190350877-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | OPRK1, F5, F12 | VDR 751/4885ADORA3 1080/4885SLC6A2 740/4885 |
| US-20190275010-A1 | COMBINATION THERAPY COMPRISING A THIAZOLE AND A SECOSTEROID TO TREAT SKIN CONDITIONS | NR3C2, CYP24A1, HSD11B2 | VDR 32/4885ADORA3 3559/4885SLC6A2 998/4885 |
| US-20220033360-A1 | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES | SCNN1G, SI, PTGER4 | VDR 746/4885ADORA3 1505/4885SLC6A2 236/4885 |
| US-11555007-B2 | Compositions and methods for the treatment of neurological diseases | SCNN1G, PMP22, TTR | VDR 2273/4885ADORA3 2027/4885SLC6A2 43/4885 |
| US-20230001012-A1 | COCRYSTALS OF STEROID AND SECOSTEROID COMPOUNDS AND COMPOSITIONS COMPRISING THEM | HSD3B1, HSD3B2, NR3C2 | VDR 234/4885ADORA3 3162/4885SLC6A2 1144/4885 |
| US-20190209585-A1 | COMBINATION THERAPY COMPRISING A POLYUNSATURATED KETONE AND A SECOSTEROID | HSD3B1, HSD3B2, HSD17B13 | VDR 67/4885ADORA3 1815/4885SLC6A2 2498/4885 |
| US-20220105052-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN | OPRK1, F5, F12 | VDR 776/4885ADORA3 1019/4885SLC6A2 836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.